Deciphera Pharmaceuticals...

NASDAQ: DCPH · Real-Time Price · USD
25.59
0.02 (0.08%)
At close: Jun 10, 2024, 10:00 PM

Deciphera Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-194.94M -178.93M -299.96M
Depreciation & Amortization
2.1M 2.95M 3.01M
Stock-Based Compensation
50.6M 51.94M 46.08M
Other Working Capital
1.95M -28.07M 16.84M
Other Non-Cash Items
4.47M 2.83M 7.45M
Deferred Income Tax
-7.4M n/a 1.78M
Change in Working Capital
-1.54M -31.65M 820K
Operating Cash Flow
-146.7M -152.86M -240.82M
Capital Expenditures
-778K -841K -5.97M
Cash Acquisitions
-13.33M 33.47M -4M
Purchase of Investments
-322.57M -322.77M -335.38M
Sales Maturities Of Investments
335.9M 289.3M 518.2M
Other Investing Acitivies
13.33M -33.47M 3.99M
Investing Cash Flow
12.55M -34.31M 176.85M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
152M 164.99M 14.89M
Financial Cash Flow
152M 164.99M 14.89M
Net Cash Flow
18.77M -22.32M -48.83M
Free Cash Flow
-147.47M -153.7M -246.79M